Table 6.

Experimental design of urolithiasis induction and anti-urolithiasis activity in the in vivo.

(A)
Group No.	Day	Treatment
1	2 weeks	Normal Control (sterilized water)
2		0.2% EG, as acute model
3		0.4% EG, as acute model
4	4 weeks	Normal Control (sterilized water)
5		0.2% EG, as chronic model
6		0.4% EG, as chronic model
(B)
Group No.	Day	Treatment (IP)
A	2 weeks	Normal Control (saline)
B		Control (0.4% EG)
C		0.4% EG + low drug
D		0.4% EG + high drug